Literature DB >> 15155561

High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies.

Marc Fiedler1, Elisabeth Müller-Holzner, Hans-Peter Viertler, Andreas Widschwendter, Andreas Laich, Gerald Pfister, Gilles A Spoden, Pidder Jansen-Dürr, Werner Zwerschke.   

Abstract

High-risk human papillomaviruses (HPVs) are major etiological agents of cervical cancer. Despite excellent epidemiological evidence for a direct role of HPV-16 in cervical carcinogenesis, molecular pathways underlying carcinogenesis in vivo remain obscure. The E7 gene is required for immortalization and maintenance of the transformed phenotype in vitro; however, little is known about its role for tumorigenesis in vivo. The E7 gene codes for an unstable protein the abundance of which in cervical biopsies is unknown. We show here that E7 protein levels strongly increase during cervical carcinogenesis, underlining its fundamental role in cervical cancer. The E7 protein was found predominantly in the nucleus and to a minor extent in the cytoplasm in the cervical cancer cell line Ca Ski in vitro and in invasive cervical carcinoma in situ, suggesting that nuclear resident E7 plays a major role in cervical carcinogenesis in humans. The retinoblastoma protein (pRb) is a major E7-target in vitro. We show here that pRb expression is initially upregulated in LSIL and disappears in later stages concomitant with increased E7 levels, suggesting that E7-driven degradation of pRb is involved in cervical tumorigenesis in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155561     DOI: 10.1096/fj.03-1332fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  21 in total

1.  Detection of human papillomavirus type 18 E7 oncoprotein in cervical smears: a feasibility study.

Authors:  Daniela Ehehalt; Barbara Lener; Haymo Pircher; Kerstin Dreier; Heiko Pfister; Andreas M Kaufmann; Sergio Frangini; Sigrun Ressler; Elisabeth Müller-Holzner; Markus Schmitt; Daniela Höfler; Ursula Rostek; Andreas Kaiser; Andreas Widschwendter; Werner Zwerschke; Pidder Jansen-Dürr
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

2.  Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity.

Authors:  Xin Wang; Mei Qi; Xiuping Yu; Yan Yuan; Weiming Zhao
Journal:  J Gen Virol       Date:  2012-03-21       Impact factor: 3.891

3.  Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16.

Authors:  W Li; R A Anderson
Journal:  Oncogene       Date:  2013-02-18       Impact factor: 9.867

4.  Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function.

Authors:  Amy Baldwin; Kyung-Won Huh; Karl Münger
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile.

Authors:  Andres Castillo; Francisco Aguayo; Chihaya Koriyama; Miyerlandi Torres; Edwin Carrascal; Alejandro Corvalan; Juan-P Roblero; Cecilia Naquira; Mariana Palma; Claudia Backhouse; Jorge Argandona; Tetsuhiko Itoh; Karem Shuyama; Yoshito Eizuru; Suminori Akiba
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

6.  Analysis of human papillomavirus E7 protein status in C-33A cervical cancer cells.

Authors:  Andreas Kaiser; Brigitte Jenewein; Haymo Pircher; Ursula Rostek; Pidder Jansen-Dürr; Werner Zwerschke
Journal:  Virus Genes       Date:  2014-10-19       Impact factor: 2.332

7.  Identification of the nuclear localization and export signals of high risk HPV16 E7 oncoprotein.

Authors:  Alixandra A Knapp; Patrick M McManus; Katy Bockstall; Junona Moroianu
Journal:  Virology       Date:  2008-11-08       Impact factor: 3.616

Review 8.  Aberrant cell cycle regulation in cervical carcinoma.

Authors:  Young Tae Kim; Min Zhao
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

9.  Characterization of the transport signals that mediate the nucleocytoplasmic traffic of low risk HPV11 E7.

Authors:  Courtney H McKee; Zeynep Onder; Aditya Ashok; Rebeca Cardoso; Junona Moroianu
Journal:  Virology       Date:  2013-05-29       Impact factor: 3.616

10.  The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7.

Authors:  Tanmayi P Mankame; Mark W Lingen
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.